You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

ramucirumab

Showing 26 - 50 of 80
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Stomach Tumors Trial in Milan (RAMUCIRUMAB, Paclitaxel, FOLFOX 4)

Recruiting
  • Stomach Neoplasms
  • RAMUCIRUMAB
  • +4 more
  • Milan, Italy
    Maria Di Bartolomeo
Sep 3, 2021

Colorectal Cancer Trial in Germany (Ramucirumab, TAS 102)

Recruiting
  • Colorectal Cancer
  • Ramucirumab
  • TAS 102
  • Altenburg, Germany
  • +28 more
Feb 15, 2022

Stomach Cancer, Stomach Tumor, Gastric Cancer Trial in France (Ramucirumab, Paclitaxel)

Recruiting
  • Stomach Cancer
  • +3 more
  • Abbeville, France
  • +37 more
Mar 23, 2022

Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma, Esophageal Adenocarcinoma Trial in Worldwide (tucatinib,

Active, not recruiting
  • Gastric Adenocarcinoma
  • +2 more
  • Birmingham, Alabama
  • +47 more
Oct 27, 2022

Metastatic Esophageal Carcinoma, Metastatic Gastric Carcinoma, Metastatic Gastroesophageal Junction Adenocarcinoma Trial in

Active, not recruiting
  • Metastatic Esophageal Carcinoma
  • +12 more
  • Corona, California
  • +31 more
Aug 9, 2022

Desmoplastic Small Round Cell Tumor Trial in Worldwide (Ramucirumab, Cyclophosphamide, Vinorelbine)

Active, not recruiting
  • Desmoplastic Small Round Cell Tumor
  • Ramucirumab
  • +2 more
  • Phoenix, Arizona
  • +50 more
Jan 18, 2023

Synovial Sarcoma Trial in Worldwide (Ramucirumab, Gemcitabine, Docetaxel)

Suspended
  • Synovial Sarcoma
  • Ramucirumab
  • +2 more
  • Birmingham, Alabama
  • +55 more
Nov 23, 2022

Pediatric Solid Tumor, Refractory Tumor, Recurrent Tumor Trial in United States (Ramucirumab)

Completed
Has Results
  • Pediatric Solid Tumor
  • +3 more
  • Ramucirumab
  • Birmingham, Alabama
  • +20 more
Jul 23, 2021

Clinical Stage III Gastric Cancer AJCC v8, Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8, Clinical Stage

Recruiting
  • Clinical Stage III Gastric Cancer AJCC v8
  • +30 more
  • Scottsdale, Arizona
  • +11 more
Apr 4, 2022

Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma Trial in Seoul (Ramucirumab, Paclitaxel)

Completed
  • Gastric Adenocarcinoma
  • Gastroesophageal Junction Adenocarcinoma
  • Seoul, Korea, Republic of
    Samsung Medical Center
Nov 17, 2020

Advanced Cancer, Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma Trial in Boston, New York, Nashville

Completed
Has Results
  • Advanced Cancer
  • +5 more
  • Boston, Massachusetts
  • +3 more
Nov 24, 2020

NSCLC Trial in Pittsburgh (ramucirumab, nab-paclitaxel)

Completed
Has Results
  • Non-small Cell Lung Cancer
  • Pittsburgh, Pennsylvania
    UPMC Hillman Cancer Center
Oct 23, 2020

Solid Tumor, Colorectal Cancer, Cholangiocarcinoma Trial in France, United States (TRK-950, Irinotecan, Leucovorin)

Recruiting
  • Solid Tumor
  • +11 more
  • TRK-950
  • +14 more
  • Scottsdale, Arizona
  • +13 more
Oct 2, 2022

Esophagogastric Adenocarcinoma Trial in New York (Crenolanib, Ramucirumab, Paclitaxel)

Completed
  • Esophagogastric Adenocarcinoma
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Jul 17, 2020

Adenocarcinoma Trial in Chicago (Trastuzumab, ABT-806, Bemarituzumab)

Completed
Has Results
  • Adenocarcinoma
  • Chicago, Illinois
    University of Chicago
Mar 15, 2021

Gastric Adenocarcinoma, Adenocarcinoma of the Gastroesophageal Junction, NSCLC Trial in Worldwide (Ramucirumab, Pembrolizumab)

Completed
  • Gastric Adenocarcinoma
  • +4 more
  • New Haven, Connecticut
  • +21 more
Aug 17, 2022

Solid Tumors Trial in Worldwide (LY3127804, Ramucirumab, Paclitaxel)

Completed
  • Solid Tumors
  • Nashville, Tennessee
  • +4 more
Oct 16, 2020

Stage IV NSCLC Trial (Ramucirumab, Docetaxel)

Withdrawn
  • Stage IV Non-small Cell Lung Cancer
  • (no location specified)
Jun 8, 2020

Metastatic NSCLC Trial in Worldwide (Ramucirumab, Placebo, Erlotinib)

Active, not recruiting
Has Results
  • Metastatic Non-Small Cell Lung Cancer
  • Ramucirumab
  • +4 more
  • Los Angeles, California
  • +109 more
Apr 18, 2022

Gastric Cancer, Gastroesophageal Junction Adenocarcinoma, Gastric Adenocarcinoma Trial in Worldwide (Evorpacept (ALX148),

Recruiting
  • Gastric Cancer
  • +2 more
  • Evorpacept (ALX148)
  • +3 more
  • Anaheim, California
  • +54 more
Jan 23, 2023

Solid Tumor, Microsatellite Instability-High (MSI-H) Solid Tumors, Cutaneous Melanoma Trial in Worldwide (LY3300054,

Active, not recruiting
  • Solid Tumor
  • +4 more
  • Nashville, Tennessee
  • +14 more
Jul 21, 2022

Locally Advanced Unresectable Gastric Adenocarcinoma, Metastatic Gastroesophageal Junction Adenocarcinoma, Metastatic

Withdrawn
  • Locally Advanced Unresectable Gastric Adenocarcinoma
  • +5 more
  • Liposomal Irinotecan
  • +3 more
  • Los Angeles, California
    USC / Norris Comprehensive Cancer Center
Mar 25, 2020

Metastatic Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma Trial in Japan, Korea, Republic of, Taiwan

Completed
Has Results
  • Metastatic Gastric Adenocarcinoma
  • Gastroesophageal Junction Adenocarcinoma
  • Ramucirumab
  • +4 more
  • Akashi, Japan
  • +33 more
Feb 23, 2022

Carcinoma, NSCLC Trial in Worldwide (nivolumab, ipilimumab, cabozantinib)

Withdrawn
  • Carcinoma, Non-small Cell Lung Cancer
  • nivolumab
  • +5 more
  • Detroit, Michigan
  • +22 more
Mar 8, 2022

Gastric Cancer, Gastroesophageal Junction Cancer Trial in United States (Ramucirumab, Trastuzumab, Capecitabine)

Terminated
Has Results
  • Gastric Cancer
  • Gastroesophageal Junction Cancer
  • Ramucirumab
  • +3 more
  • Basking Ridge, New Jersey
  • +5 more
Jan 6, 2020